Regulus Therapeutics to Present New In Vivo Data for microRNA-21 in Kidney ... - PR Newswire (press release) PDF Print
PR Newswire (press release)
... a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced presentations on its preclinical programs for the treatment of fibrosis at the American Association of Nephrology "Kidney

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.